1. P. S. Watson, B. Jiang, B. Scott, Org. Lett. 2(2000),3679.
2. George H. Finer, and E,A, Rovenstine;, The Application of A new Piperidones derivatives to Spinal Anaesthesia: Preliminary Report, Anaesthesiology, Nov 1947,Vol-8,619.
3. Nadin, Contemp. Org. Synth.,1997, 4,387.
4. E. A. Sausville, Current Medicinal Chemistry - Anti-Cancer Agents 3, (2003),47.
5. P. D. Bailey, P. A. Millwood, P. D. Smith, J. Chem. Soc., Chem. Commun. (1998)633.
6. Mitchinson, A. Nadin, J. Chem. Soc., Perkin Trans.1 (2000),2862.
7. S. Laschat, T. Dickner. Synthesis(2000)1781.
8. Francisa, P. T.;Palmerb, A. M.; Snapeb, M.; Wilcockc, G. K., The cholinergic hypothesis of Alzheimer’s disease: a review of progress. J NeurolNeurosurg Psychiatry, 1999, 66, 137-147.
9. Marc, J.;Ezoulin, M.; Shao, B.; Xia, Z.; Xie, Q.; Li, J.; Cui, J.; Wang, H.; Dong, C.; Zhao, Y.; Massicot, F.; Qiu, Z.; Heymans, F.; Chen, H., Novel piperazine derivative PMS1339 exhibits tri-functional properties and cognitive improvement in mice. International Journal of Neuropsychopharmacology, 2009, 12,1409–1419.
10. Ellman, G.L.; Courtney, K.D.; Andres Jr, V.; Featherstone, R.M., A new and rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacology 1961, 7 (2),88-95.
11. Perry, N.S.L.; Houghton, P.J.; Theobald, A.; Jenner, P.; Perry, E.K., In-vitro inhibition of human erythrocyte acetylcholinesterase by Salvia lavandulaefolia essential oil and constituent terpenes. Journal of Pharmacy and Pharmacology2000, 52(7),895-902.
12. L. A. Gandon, A. G. Russel, T. Guveli, A. E. Brodwolf, B. M. Kariuki, N. Spencer, J. S. Snaith, J. Org. Chem. 71,(2006),5198.